UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of August 2021
Commission File Number 001-35751
STRATASYS LTD.
(Translation of registrant’s name into English)
c/o Stratasys, Inc. 7665 Commerce Way Eden Prairie, Minnesota 55344 |
1 Holtzman Street, Science Park P.O. Box 2496 Rehovot, Israel 76124 | |
(Addresses of principal executive offices) |
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
CONTENTS
Quarterly Results of Operations
On August 5, 2021, Stratasys Ltd. (“we” or “us”) announced our financial results for the second quarter ended June 30, 2021. A copy of our press release announcing our results is furnished as Exhibit 99.1 to this Report of Foreign Private Issuer on Form 6-K (this “Form 6-K”) and is incorporated herein by reference.
In conjunction with the conference call being held on August 5, 2021 to discuss our results, we are furnishing a copy of the slide presentation that provides supplemental information regarding our business and our financial results, and which will be referenced on that conference call. We have attached that presentation to this Form 6-K as Exhibit 99.2, which exhibit is incorporated herein by reference.
The information in this Form 6-K, including Exhibits 99.1 and 99.2, shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
STRATASYS LTD. | ||
Dated: August 5, 2021 | By: | /s/ Lilach Payorski |
Name: | Lilach Payorski | |
Title: | Chief Financial Officer |
2
EXHIBIT INDEX
The following exhibits are furnished as part of this Form 6-K:
3
Exhibit 99.1
Stratasys Releases Second Quarter 2021 Financial Results
● | Revenue of $147.0 million |
● | GAAP net loss of $20.2 million, or $0.31 per diluted share, and non-GAAP net loss of $1.6 million, or $0.02 per diluted share |
● | Generated $5.6 million of cash from operations |
● | Furthering penetration into Healthcare - introduced J5 MediJet medical 3D printer |
● | $522.7 million cash and equivalents and no debt at quarter end |
MINNEAPOLIS & REHOVOT, Israel--(BUSINESS WIRE) - August 5, 2021 Stratasys Ltd. (NASDAQ: SSYS) announced financial results for the second quarter of 2021.
Second Quarter 2021 Financial Results Summary Compared to Second Quarter 2020:
● | Revenue of $147.0 million compared to $117.6 million. |
● | GAAP gross margin was 43.0%, compared to 37.2%. |
● | Non-GAAP gross margin was 47.5%, compared to 45.4%. |
● | GAAP operating loss was $22.7 million, compared to an operating loss of $29.3 million. |
● | Non-GAAP operating loss was $2.6 million, compared to an operating loss of $8.1 million. |
● | GAAP net loss was $20.2 million, or $0.31 per diluted share, compared to a net loss of $28.0 million, or $0.51 per diluted share. |
● | Non-GAAP net loss was $1.6 million, or $0.02 per diluted share, compared to a net loss of $7.4 million, or $0.13 per diluted share. |
● | Adjusted EBITDA was $3.5 million, compared to $(1.6) million. |
● | Cash provided by operations of $5.6 million, compared to cash use of $9.7 million. |
Dr. Yoav Zeif, Stratasys’s Chief Executive Officer stated, “Our strong second quarter results were highlighted by a 25% year over year revenue improvement with growth from all regions and all business lines. Our focus on manufacturing gained further traction, we increased the monetization and ecosystem partnerships of our software business, and we expanded our medical and dental offerings, advancing our plans for further penetration in the healthcare industry.”
Dr. Zeif continued, “The transition of the 3D printing industry from prototyping to mass production is ongoing, and our commitment to being the first choice in polymer 3D printing positions us to be the main benefactor. We are investing across technology, software, materials, and talent to capture increased market share that we expect will yield significant returns and sustained profitability in the years to come.”
Financial Outlook: (TBD)
Based on current market conditions and assuming that the impact related to the pandemic does not impede the economic environment further, the Company is reiterating and updating its outlook as follows:
● | Third quarter 2021 revenue of approximately 17% - 18% growth year-over-year. Fourth quarter revenue is expected to be sequentially higher than third quarter. |
● | Full year operating expenses expected to rise approximately $30 million compared to 2020, primarily due to the return of employees to a full-time schedule starting January 1, 2021, as well as operating costs as the markets gradually re-open. |
● | Full year capital expenditures anticipated to range from $24 million to $30 million. |
● | Longer term, the Company continues to expect significant leverage benefit from its investments as revenue growth should start to accelerate in 2022 and beyond. |
Stratasys Ltd. Second Quarter 2021 Webcast and Conference Call Details
The Company plans to webcast its conference call to discuss its second quarter 2021 financial results on Thursday, August 5, 2021 at 8:30 a.m. (ET).
The investor conference call will be available via live webcast on the Stratasys Web site at investors.stratasys.com, or directly at the following web address:
https://78449.themediaframe.com/dataconf/productusers/ssys/mediaframe/46027/indexl.html
To participate by telephone, the U.S. toll-free number is 877-407-0619 and the international dial-in is +1-412-902-1012. Investors are advised to dial into the call at least ten minutes prior to the call to register. The webcast will be available for six months at investors.stratasys.com, or by accessing the above-provided web address.
Stratasys is leading the global shift to additive manufacturing with innovative 3D printing solutions for industries such as aerospace, automotive, consumer products and healthcare. Through smart and connected 3D printers, polymer materials, a software ecosystem, and parts on demand, Stratasys solutions deliver competitive advantages at every stage in the product value chain. The world’s leading organizations turn to Stratasys to transform product design, bring agility to manufacturing and supply chains, and improve patient care.
To learn more about Stratasys, visit www.stratasys.com, the Stratasys blog, Twitter, LinkedIn, or Facebook. Stratasys reserves the right to utilize any of the foregoing social media platforms, including the company’s websites, to share material, non-public information pursuant to the SEC’s Regulation FD. To the extent necessary and mandated by applicable law, Stratasys will also include such information in its public disclosure filings.
Stratasys is a registered trademark and the Stratasys signet is a trademark of Stratasys Ltd. and/or its subsidiaries or affiliates. All other trademarks are the property of their respective owners.
2
Cautionary Statement Regarding Forward-Looking Statements
The statements in this press release regarding Stratasys’ strategy, and the statements regarding its projected future financial performance, including the financial guidance concerning its expected results for 2021, are forward-looking statements reflecting management’s current expectations and beliefs. These forward-looking statements are based on current information that is, by its nature, subject to rapid and even abrupt change. Due to risks and uncertainties associated with Stratasys’ business, actual results could differ materially from those projected or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to: the degree of our success at introducing new or improved products and solutions that gain market share; the degree of growth of the 3D printing market generally; the impact of potential shifts in the prices or margins of the products that we sell or services that we provide, including due to a shift towards lower margin products or services; the impact of competition and new technologies; potential further charges against earnings that we could be required to take due to impairment of additional goodwill or other intangible assets; the extent of our success at successfully consummating acquisitions or investments in new businesses, technologies, products or services; the strength and duration of, and degree of recovery from, the COVID-19 pandemic in the markets in which we operate; potential changes in our management and board of directors; global market, political and economic conditions, and in the countries in which we operate in particular (including risks related to the impact of coronavirus on our supply chain and business); costs and potential liability relating to litigation and regulatory proceedings; risks related to infringement of our intellectual property rights by others or infringement of others’ intellectual property rights by us; the extent of our success at maintaining our liquidity and financing our operations and capital needs; the impact of tax regulations on our results of operations and financial condition; and those additional factors referred to in Item 3.D “Key Information - Risk Factors”, Item 4, “Information on the Company”, Item 5, “Operating and Financial Review and Prospects,” and all other parts of our Annual Report on Form 20-F for the year ended December 31, 2020, which we filed with the U.S. Securities and Exchange Commission, or SEC, on March 1, 2021 (the “2020 Annual Report”). Readers are urged to carefully review and consider the various disclosures made throughout our 2020 Annual Report and the Reports of Foreign Private Issuer on Form 6-K that attach Stratasys’ unaudited, condensed consolidated financial statements and its review of its results of operations and financial condition, for the quarterly periods throughout 2021, which will be furnished to the SEC throughout 2021 (including on or about the date hereof), and our other reports filed with or furnished to the SEC, which are designed to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects. Any guidance provided, and other forward-looking statements made, in this press release are provided or made (as applicable) as of the date hereof, and Stratasys undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Use of Non-GAAP Financial Measures
The non-GAAP data included herein, which excludes certain items as described below, are non-GAAP financial measures. Our management believes that these non-GAAP financial measures are useful information for investors and shareholders of our Company in gauging our results of operations (i) on an ongoing basis after excluding mergers, acquisitions and divestments related expense or gains and reorganization-related charges or gains, and (ii) excluding non-cash items such as stock-based compensation expenses, acquired intangible assets amortization, including intangible assets amortization related to equity method investments, impairment of long-lived assets and goodwill, revaluation of our investments and the corresponding tax effect of those items. These non-GAAP adjustments either do not reflect actual cash outlays that impact our liquidity and our financial condition or have a non-recurring impact on the statement of operations, as assessed by management. These non-GAAP financial measures are presented to permit investors to more fully understand how management assesses our performance for internal planning and forecasting purposes. The limitations of using these non-GAAP financial measures as performance measures are that they provide a view of our results of operations without including all items indicated above during a period, which may not provide a comparable view of our performance to other companies in our industry. Investors and other readers should consider non-GAAP measures only as supplements to, not as substitutes for or as superior measures to, the measures of financial performance prepared in accordance with GAAP. Reconciliation between results on a GAAP and non-GAAP basis is provided in a table below.
Yonah Lloyd
CCO, VP Investor Relations
Yonah.Lloyd@stratasys.com
Source: Stratasys Ltd.
3
Stratasys Ltd.
Consolidated Balance Sheets
(Unaudited)
(in thousands, except share data)
June 30, | December 31, | |||||||
2021 | 2020 | |||||||
ASSETS | ||||||||
Current assets | ||||||||
Cash and cash equivalents | $ | 343,733 | $ | 272,092 | ||||
Short-term deposits | 179,000 | 27,000 | ||||||
Accounts receivable, net of allowance for credit losses of $0.8 and $0.9 million as of June 30, 2021 and December 31, 2020 | 109,969 | 106,068 | ||||||
Inventories | 124,227 | 131,672 | ||||||
Prepaid expenses | 7,288 | 6,717 | ||||||
Other current assets | 21,189 | 16,943 | ||||||
Total current assets | 785,406 | 560,492 | ||||||
Non-current assets | ||||||||
Property, plant and equipment, net | 201,080 | 201,232 | ||||||
Goodwill | 39,686 | 35,694 | ||||||
Other intangible assets, net | 124,257 | 131,569 | ||||||
Operating lease right-of-use assets | 17,514 | 21,298 | ||||||
Other non-current assets | 55,081 | 39,717 | ||||||
Total non-current assets | 437,618 | 429,510 | ||||||
Total assets | $ | 1,223,024 | $ | 990,002 | ||||
LIABILITIES AND EQUITY | ||||||||
Current liabilities | ||||||||
Accounts payable | $ | 42,001 | $ | 16,987 | ||||
Accrued expenses and other current liabilities | 30,134 | 31,061 | ||||||
Accrued compensation and related benefits | 29,270 | 25,659 | ||||||
Deferred revenues - short term | 48,943 | 49,165 | ||||||
Operating lease liabilities - short term | 8,248 | 9,282 | ||||||
Total current liabilities | 158,596 | 132,154 | ||||||
Non-current liabilities | ||||||||
Deferred revenues - long term | 15,661 | 14,227 | ||||||
Operating lease liabilities - long term | 9,553 | 12,567 | ||||||
Contingent consideration | 40,436 | 37,400 | ||||||
Other non-current liabilities | 37,206 | 34,059 | ||||||
Total non-current liabilities | 102,856 | 98,253 | ||||||
Total liabilities | 261,452 | 230,407 | ||||||
Redeemable non-controlling interests | 227 | 227 | ||||||
Equity | ||||||||
Ordinary shares, NIS 0.01 nominal value, authorized 180,000 thousands shares; 65,396 thousands shares and 56,617 thousands shares issued and outstanding at June 30, 2021 and December 31, 2020, respectively | 181 | 155 | ||||||
Additional paid-in capital | 2,992,833 | 2,753,955 | ||||||
Accumulated other comprehensive loss | (6,703 | ) | (8,846 | ) | ||||
Accumulated deficit | (2,024,966 | ) | (1,985,896 | ) | ||||
Total equity | 961,345 | 759,368 | ||||||
Total liabilities and equity | $ | 1,223,024 | $ | 990,002 |
4
Stratasys Ltd.
Consolidated Statements of Operations
(in thousands, except per share data)
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2021 | 2020 | 2021 | 2020 | |||||||||||||
(unaudited) | (unaudited) | (unaudited) | (unaudited) | |||||||||||||
Net sales | ||||||||||||||||
Products | $ | 100,305 | $ | 73,877 | $ | 190,629 | $ | 157,049 | ||||||||
Services | 46,700 | 43,746 | 90,565 | 93,481 | ||||||||||||
147,005 | 117,623 | 281,194 | 250,530 | |||||||||||||
Cost of sales | ||||||||||||||||
Products | 49,731 | 39,969 | 96,651 | 79,217 | ||||||||||||
Services | 34,004 | 33,918 | 65,696 | 67,707 | ||||||||||||
83,735 | 73,887 | 162,347 | 146,924 | |||||||||||||
Gross profit | 63,270 | 43,736 | 118,847 | 103,606 | ||||||||||||
Operating expenses | ||||||||||||||||
Research and development, net | 22,437 | 21,303 | 43,038 | 45,497 | ||||||||||||
Selling, general and administrative | 63,557 | 51,711 | 116,891 | 107,287 | ||||||||||||
85,994 | 73,014 | 159,929 | 152,784 | |||||||||||||
Operating loss | (22,724 | ) | (29,278 | ) | (41,082 | ) | (49,178 | ) | ||||||||
Financial income (expenses), net | (372 | ) | 149 | (749 | ) | (680 | ) | |||||||||
Loss before income taxes | (23,096 | ) | (29,129 | ) | (41,831 | ) | (49,858 | ) | ||||||||
Income tax benefit | (4,368 | ) | (2,128 | ) | (5,310 | ) | (1,907 | ) | ||||||||
Share in losses of associated companies | (1,431 | ) | (950 | ) | (2,549 | ) | (1,788 | ) | ||||||||
Net loss | (20,159 | ) | (27,951 | ) | (39,070 | ) | (49,739 | ) | ||||||||
Net income (loss) attributable to non-controlling interests | - | 35 | - | (50 | ) | |||||||||||
Net loss attributable to Stratasys Ltd. | $ | (20,159 | ) | $ | (27,986 | ) | $ | (39,070 | ) | $ | (49,689 | ) | ||||
Net loss per ordinary share attributable to Stratasys Ltd. | ||||||||||||||||
Basic | $ | (0.31 | ) | $ | 0.51 | $ | (0.63 | ) | $ | (0.91 | ) | |||||
Diluted | $ | (0.31 | ) | $ | 0.51 | $ | (0.63 | ) | $ | (0.91 | ) | |||||
Weighted average ordinary shares outstanding | ||||||||||||||||
Basic | 64,908 | 54,917 | 61,796 | 54,733 | ||||||||||||
Diluted | 64,908 | 54,917 | 61,796 | 54,733 |
5
Three Months Ended June 30, | ||||||||||||||||||||||||||
2021 | Non-GAAP | 2021 | 2020 | Non-GAAP | 2020 | |||||||||||||||||||||
GAAP | Adjustments | Non-GAAP | GAAP | Adjustments | Non-GAAP | |||||||||||||||||||||
U.S. dollars and shares in thousands (except per share amounts) | ||||||||||||||||||||||||||
Gross profit (1) | $ | 63,270 | $ | 6,616 | $ | 69,886 | $ | 43,736 | $ | 9,612 | $ | 53,348 | ||||||||||||||
Operating income (loss) (1,2) | (22,724 | ) | 20,133 | (2,591 | ) | (29,278 | ) | 21,228 | (8,050 | ) | ||||||||||||||||
Net income (loss) attributable to Stratasys Ltd. (1,2,3) | (20,159 | ) | 18,581 | (1,578 | ) | (27,986 | ) | 20,634 | (7,352 | ) | ||||||||||||||||
Net income (loss) per diluted share attributable to Stratasys Ltd. (4) | $ | (0.31 | ) | $ | 0.29 | $ | (0.02 | ) | $ | (0.51 | ) | $ | 0.38 | $ | (0.13 | ) | ||||||||||
(1) | Acquired intangible assets amortization expense | 5,518 | 4,065 | |||||||||||||||||||||||
Non-cash stock-based compensation expense | 788 | 497 | ||||||||||||||||||||||||
Restructuring and other related costs | 310 | 5,050 | ||||||||||||||||||||||||
6,616 | 9,612 | |||||||||||||||||||||||||
(2) | Acquired intangible assets amortization expense | 2,200 | 2,125 | |||||||||||||||||||||||
Non-cash stock-based compensation expense | 7,189 | 5,614 | ||||||||||||||||||||||||
Restructuring and other related costs | 350 | 3,798 | ||||||||||||||||||||||||
Revaluation of investments | 2,201 | - | ||||||||||||||||||||||||
Contingent consideration | 202 | - | ||||||||||||||||||||||||
Other expenses | 1,375 | 79 | ||||||||||||||||||||||||
13,517 | 11,616 | |||||||||||||||||||||||||
20,133 | 21,228 | |||||||||||||||||||||||||
(3) | Corresponding tax effect | (1,637 | ) | (669 | ) | |||||||||||||||||||||
Equity method related amortization, divestments and impairments | 85 | 75 | ||||||||||||||||||||||||
$ | 18,581 | $ | 20,634 | |||||||||||||||||||||||
(4) | Weighted average number of ordinary shares outstanding- Diluted | 64,908 | 64,908 | 54,917 | 54,917 |
6
Six Months Ended June 30, | ||||||||||||||||||||||||||
2021 | Non-GAAP | 2021 | 2020 | Non-GAAP | 2020 | |||||||||||||||||||||
GAAP | Adjustments | Non-GAAP | GAAP | Adjustments | Non-GAAP | |||||||||||||||||||||
U.S. dollars and shares in thousands (except per share amounts) | ||||||||||||||||||||||||||
Gross profit (1) | $ | 118,847 | $ | 13,685 | $ | 132,532 | $ | 103,606 | $ | 14,026 | $ | 117,632 | ||||||||||||||
Operating income (loss) (1,2) | (41,082 | ) | 35,918 | (5,164 | ) | (49,178 | ) | 32,719 | (16,459 | ) | ||||||||||||||||
Net income (loss) attributable to Stratasys Ltd. (1,2,3) | (39,070 | ) | 33,692 | (5,378 | ) | (49,689 | ) | 31,771 | (17,919 | ) | ||||||||||||||||
Net income (loss) per diluted share attributable to Stratasys Ltd. (4) | $ | (0.63 | ) | $ | 0.55 | $ | (0.09 | ) | $ | (0.91 | ) | $ | 0.58 | $ | (0.33 | ) | ||||||||||
(1) | Acquired intangible assets amortization expense | 10,873 | 8,130 | |||||||||||||||||||||||
Non-cash stock-based compensation expense | 1,422 | 899 | ||||||||||||||||||||||||
Restructuring and other related costs | 1,390 | 4,997 | ||||||||||||||||||||||||
13,685 | 14,026 | |||||||||||||||||||||||||
(2) | Acquired intangible assets amortization expense | 4,393 | 4,267 | |||||||||||||||||||||||
Non-cash stock-based compensation expense | 13,760 | 10,119 | ||||||||||||||||||||||||
Restructuring and other related costs | 2,159 | 3,829 | ||||||||||||||||||||||||
Revaluation of investments | (1,469 | ) | - | |||||||||||||||||||||||
Contingent consideration | 393 | - | ||||||||||||||||||||||||
Other expenses | 2,997 | 478 | ||||||||||||||||||||||||
22,233 | 18,693 | |||||||||||||||||||||||||
35,918 | 32,719 | |||||||||||||||||||||||||
(3) | Corresponding tax effect | (2,394 | ) | (1,100 | ) | |||||||||||||||||||||
Equity method related amortization, divestments and impairments | 168 | 152 | ||||||||||||||||||||||||
$ | 33,692 | $ | 31,771 | |||||||||||||||||||||||
(4) | Weighted average number of ordinary shares outstanding- Diluted | 61,796 | 61,796 | 54,733 | 54,733 |
7
Exhibit 99.2
Second Quarter 2021 Results August 5th, 2021 Speakers Dr. Yoav Zeif – CEO Lilach Payorski – CFO Yonah Lloyd – CCO / VP Investor Relations
US Toll - Free dial - in: 1 - 877 - 407 - 0619 International dial - in +1 - 412 - 902 - 1012 Live webcast and replay: https://78449.themediaframe.com/dataconf/productusers/ssys/mediaframe/44880/indexl.html Conference Call & Webcast Details
Forward - Looking Statements 3 Cautionary Statement Regarding Forward - Looking Statements The statements in this press release regarding Stratasys ' strategy, and the statements regarding its projected future financial performance, including the financial guidance concerning its expected results for 2021, are forward - looking statements reflecting management's current expectations and beliefs. These forward - looking statements are based on current information that is, by its nature, subject to rapid and even abrupt change. Due to risks and uncertainties associated with Stratasys ' business, actual results could differ materially from those projected or implied by these forward - looking statements. These risks and uncertainties include, but are not limited to: the degree of our success at introducing new or improved products and solutions that gain market share; the degree of growth of the 3D printing market generally; the duration and degree of severity of, and strength of recovery from, the global COVID - 19 pandemic; the impact of potential shifts in the prices or margins of the products that we sell or services that we provide, including due to a shift towards lo wer margin products or services; the impact of competition and new technologies; the extent of our success at successfully integrating into our existing business, or making additional, acquisitions or investments in new businesses, technologies, products or services; potential changes in our management and board of directors; global market, political and economic conditions, and in the countries in which we operate in particular (including risks related to the impact of coronavirus on o ur supply chain and business); potential further charges against earnings that we could be required to take due to impairment of additional goodwill or other intangible assets that we have recently acquired or may acquire in the future; costs and potential liability relating to litigation and regulatory proceedings; risks related to infringement of our intellectual prop ert y rights by others or infringement of others' intellectual property rights by us; the extent of our success at maintaining our liquidity and financing our operations and capital needs; the impact of tax regulations on our results of operations and financial condition; and those additional factors referred to in Item 3.D “Key Information - Risk Factors”, Item 4, “Information on the Company”, Item 5, “Operating and Financial Review and Prospects,” and all other parts of our Annual Report on Form 20 - F for the year ended December 31, 2020 (the “ 2020 Annual Report ”). Readers are urged to carefully review and consider the various disclosures made throughout our 2020 Annual Report and the Reports of Foreign Private Issuer on Form 6 - K that attach Stratasys ’ unaudited, condensed consolidated financial statements and its review of its results of operations and financial condition, for the quarterly periods throughout 2021, which are furnished to the SEC over the course of 2021 (including on or about the date hereof), and our other reports filed with or furnished to the SEC, which are designed to advise interested parties of the risks and factors that may affect our business, financial condition, results of operation s a nd prospects. Any guidance provided, and other forward - looking statements made, in this slide presentation are made as of the date hereof, and Stratasys undertakes no obligation to publicly update or revise any forward - looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Use of Non - GAAP Financial Information 4 Use of non - GAAP financial measures The non - GAAP data included herein, which excludes certain items as described below, are non - GAAP financial measures. Our management believes that these non - GAAP financial measures are useful information for investors and shareholders of our Company in gauging our results of operations ( i ) on an ongoing basis after excluding mergers, acquisitions and divestments related expense or gains and reorganization - related charges or gains, and (ii) excluding non - cash items such as stock - based compensation expenses, acquired intangible assets amortization, including intangible assets amortization related to equity method investments, impairment of long - lived assets and goodwill, revaluation of our investments and the corresponding tax effect of those items. These non - GAAP adjustments either do not reflect actual cash outlays that impact our liquidity and our financial condition or have a non - recurring impact on the statement of operations, as assessed by management. These non - GAAP financial measures are presented to permit investors to more fully understand how management assesses our performance for internal planning and forecasting purposes. The limitations of using these non - GAAP financial measures as performance measures are that they provide a view of our results of operations without including all items indicated above during a period, which may not provide a comparable view of our performance to other companies in our industry. Investors and other readers should consider non - GAAP measures only as supplements to, not as substitutes for or as superior measures to, the measures of financial performance prepared in accordance with GAAP. Reconciliation between results on a GAAP and non - GAAP basis is provided in a table later in this slide presentation.
CEO Opening Remarks 5 Our growth is accelerating as the industry shifts from prototyping to mass production and Stratasys offers the most innovative technologies for the fastest - growing manufacturing applications. 25% year - over - year revenue growth, highlighted by 32% HW and 39% Consumables growth. Third consecutive quarter of sustained revenue growth. Broad strength across regions and business lines as recovery from the pandemic continues. Dr. Yoav Zeif CEO
Second Quarter 2021 Highlights 6 6 Manufacturing Experience Event • 4,500+ customers and partners joined our live event on Additive Manufacturing 2.0 offerings: • Stratasys Origin One: Top - to - bottom upgrade since acquisition. • SAF - powered H350: New production - scale powder bed polymer solution. • Stratasys F770: Large, fully heated FDM printer with F123 simplicity .
Second Quarter 2021 Highlights 7 7 New J5 MediJet • All - in - one solution for multi - use, multi - material printing • Biocompatible and sterilizable materials • 510k - approved with leading medical segmentation software Dental growth • 3 technologies – PolyJet , Origin P3, stereolithography – now lets us serve the majority of this $1B+ TAM • DentaJet announced in Q1 is performing well in the market ESG initiatives • Named internal ESG leadership team • Founding member of Additive Manufacturer Green Trade Association
Software Continues to Expand / Monetization of GrabCAD Shop Online Customer Hub Launches 8 8 GrabCAD Partner Program • 6 software partners announced in first six months. • Latest is Teton Simulation, using new GrabCAD DFAM SDK. • License subscriptions enable customers to connect to all our partners. Monetizing software with cloud - based GrabCAD Shop • All - in - one workflow tool to help customers scale. • Large customers include Schneider Electric, McLaren, Virginia Tech, others. Customer Hub: Making it easier to do business with Stratasys • Over $25 million in orders placed globally in Q2. • Over 2,000 customer and partner account activations so far. • Complete dashboard view of Stratasys 3D printers, with easy ordering, and further enhancements in progress.
Competitive Advantages to Lead Polymer Additive Manufacturing 9 Broadest technology offering in sector Deep application engineering expertise Unmatched go - to - market infrastructure Resilient business model designed to scale Cloud - based software partner ecosystem Five best - in - class technologies for every step in the product lifecycle – from concept through manufacturing Network of over 200 channel partners – largest and most experienced in the industry Multi - disciplinary application engineering expertise to educate customers and drive innovation Corporate and GTM infrastructure can absorb and scale new business with operating leverage to drive profits and generate cash Unifying, comprehensive platform at heart of cloud - based strategy and growing partnerships such as Siemens, nTopology and Keyshot Delivering innovative, next - generation technologies to address the fastest growing manufacturing applications
Financial Highlights Lilach Payorski CFO 25% growth exceeded revenue outlook Produced 32% growth in systems and 39% in consumables year over year Generated $5.6m in OCF Updated outlook 10
Financial Results – Second Quarter 2021 11 GAAP Non - GAAP Q 2 - 20 Q 2 - 21 Change Y/Y Q 2 - 20 Q 2 - 21 Change Y/Y Total Revenue 117 . 6 147 . 0 25 .0% 1 17 . 6 1 47 . 0 25 .0% Gross Profit 43.7 63.3 19.6 53 .3 6 9 . 9 16.6 % Margin 37 . 2 % 4 3 . 0 % 5.8 % 4 5 .4% 4 7 . 5 % 2.1 % Operating Income (Loss) ( 2 9. 3 ) ( 22 . 7 ) 6.6 (8. 1 ) (2.6) 5. 5 % Margin - 24 . 9 % - 1 5 . 5 % 9.4 % - 6. 8 % - 1. 8 % 5 % Net Income (Loss) attributed to SSYS Ltd. ( 28 . 0 ) ( 20 . 2 ) 7 .8 ( 7 . 4 ) ( 1 . 6 ) 5 .8 % Margin - 23 . 8 % - 1 3 . 7 % 10 . 1 % - 6 . 3 % - 1 . 1 % 5. 2 % Diluted EPS (0. 51 ) (0.3 1 ) 0. 20 (0.1 3 ) (0.0 2 ) 0.1 1 Diluted Shares 54. 9 64.9 18 . 2 % 54. 9 64 . 9 18 . 2 % Note: $ in millions unless noted otherwise. All numbers and percentages rounded.
12 Note: $ in millions unless noted otherwise. All numbers and percentages rounded. Quarterly Trend 73.9 83.5 99.2 90.3 100.3 43.7 44.3 43.2 43.9 46.7 117.6 127.9 142.4 134.2 147.0 Q2' 20 Q3' 20 Q4' 20 Q1' 21 Q2' 21 Product Service Revenue Growth – Q2’21 Revenue Y/Y Y/Y (exc. FX) Product 35.8% 32.6% System 32.0% 29.2% Consumables 39.1% 35.5% Service 6.8% 5.3% Customer Support 10.0% 8.2% Revenue Driven by Product Sales Growth of Nearly 36% Customer Support Above and Consumables Near Pre - COVID Level
Gross Margins Improved from Higher Systems and Consumables Still Challenged by Rising Logistics Costs and NPI Ramp - up 13 All percentages rounded. GAAP Non - GAAP 37.2% 38.9% 46.4% 41.4% 43.0% 45.9% 43.3% 55.0% 48.1% 50.4% 22.5% 30.6% 26.6% 27.8% 27.2% Q2 '20 Q3 '20 Q4' 20 Q1 '21 Q2 '21 45.4% 46.8% 49.5% 46.7% 47.5% 52.9% 54.9% 58.7% 55.4% 56.4% 32.7% 31.3% 28.5% 28.7% 28.6% Q2 '20 Q3 '20 Q4 '20 Q1 '21 Q2 '21 Total Gross Margin Product Gross Margin Service Gross Margin
Operating Expenses Improvement Trend Ongoing 14 73.0 86.0 Q2'20 Q2'21 Q2'20 Q2'21 17.8% 61.4 72.5 Q2'20 Q2'21 Q2'20 Q2'21 Non - GAAP Operating expenses . % GAAP Operating expenses Note: $ in millions unless noted otherwise. All numbers and percentages rounded. 58.5% 62.1% 52.2% 49.3%
Operating Income and Net Earnings Improvement 15 GAAP Operating Loss Non - GAAP Operating Loss (29.3) (22.7) Q2'20 Q2'21 (8.1) (2.6) Q2'20 Q2'21 GAAP Net Loss Non - GAAP Net Loss (28.0) (20.2) Q2'20 Q2'21 (7.4) (1.6) Q2'20 Q2'21 Note: $ in millions unless noted otherwise. All numbers and percentages rounded.
Balance Sheet Strengthened to $523m Cash and Equivalents 16 Balance Sheet Items Cash Flow From Operating Activities (9.7) 5.6 Q2' 20 Q2' 21 Q2 - 20 Q1 - 21 Q2 - 21 Cash and Cash Equivalents and Short - term deposits 313.0 530.4 522.7 Accounts Receivable 102.2 102.8 110.0 Inventories 164.6 124.2 124.2 Net Working Capital 465.7 637.8 626.8 Note: $ in millions unless noted otherwise. All numbers and percentages rounded. H 1 Generated $ 2 . m Operating Cash
2021 Outlook 17 Revenue in the third quarter 2021 is expected to grow 17% - 18% compared to third quarter 2020. Fourth quarter revenue is expected to be sequentially higher. Operating expenses for 2021 are expected to be approximately $30M higher than 2020, reflecting the return to full - time work and operating costs associated with the gradual recovery of our end markets. Capital expenditures in 2021 expected to range from $24M to $30M. We are committed to growing our leadership position as the 3D printing industry shifts from prototyping to mass production.
18 CEO Summary Q2 saw accelerated growth across the business. Incremental growth coming from new platforms launching in Q4. Executing on our strategy to lead polymer 3D Printing and create long - term value.
Thank You: Q&A 19
Appendix 20
GAAP to Non - GAAP Reconciliation 21 Results of operations Stratasys Ltd Three months ended June 30, 2021 Three months ended June 30 , 2020 GAAP Adjustments Non - GAAP GAAP Adjustments Non - GAAP Gross Profit (1) $63,270 $6,616 $69,886 $ 43,736 $9,612 $53,348 Operating income (Loss) (1,2) (22,724) 20,133 (2,591) (29,278) 21,228 (8,050) Net income (Loss) attributable to Stratasys Ltd (1,2,3) (20,158) 18,581 (1,577) (27,987) 20,634 (7,353) Net income (Loss) per diluted share attributable to Stratasys Ltd (4) ($0.31) $0.29 ($0.02) ($0.51) $0.38 ($0.13) 1) Acquired intangible assets amortization expense 5,518 4,065 Non - cash stock - based compensation expense 788 497 Restructuring and other related costs 310 5,049 6,616 9,612 2) Acquired intangible assets amortization expense 2,200 2,125 Non - cash stock - based compensation expense 7,190 5,617 Restructuring and other related costs 350 3,798 Revaluation of investments 2,201 - Contingent consideration 202 - Other expenses 1,375 76 13,517 11,616 20,133 21,228 3) Corresponding tax effect (1,637) (669) Equity method related amortization, divestments and impairments 85 75 $18,581 20,634 4) Weighted average number or ordinary shares outstanding – Diluted 64,908 64,908 54,917 54,917
>
MU<;\,X\_MER2?]1"Z7/_ &Q?_"O3_BCHK:WKC0KUD-?GN.4_[4PRCO[*/YL_
MM3@G"TJO ^<1DE;Z_7^[EAH?,&M^&V+-Y>[:"0>*^]_^"(_[*U]^T+\+_C9;
MZ3'I*Z]96%DMAVM6_BQ!
M)#<)&3TB,2#B,5^&$7'YU^O'_!IHF/ W[03]-VKZ"N?I!J!_K4R&C]?@S4X2
M8]:K"3)_^O2L<#_Z]266$(+4$X;ZC]:A5L<^OO2E\"@!['#>E&2:CSO;^5)T
M;^M ".W[LD^E<[XM;%I)_M ].M;TC>6#WKGO%39MF7M0!_+!^U[XSMA^UW\6
MD>X567QQKF0>W_$QN*\[D\7V8&?M$)_'%>.M;*@'
M@9U"WI7S>4Q3G)^9_7WCM)1JQM%